<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<ns2:studies xmlns:ns2="http://webservice.caaers.cabig.nci.nih.gov">
    <ns2:study>
        <shortTitle>Study A100</shortTitle>
        <phaseCode>Phase I Trial</phaseCode>
        <otherMeddra>MedDRA v9.0</otherMeddra>
        <studyPurpose>Treatment</studyPurpose>
        <aeTermUnique>true</aeTermUnique>
        <ns2:aeTerminology>
            <ns2:ctcVersion>
                <name>3</name>
            </ns2:ctcVersion>
        </ns2:aeTerminology>
        <ns2:diseaseTerminology>
            <diseaseCodeTerm>CTEP</diseaseCodeTerm>
        </ns2:diseaseTerminology>
        <fundingSponsor>
            <organizationAssignedIdentifier>
                <value>12345</value>
            </organizationAssignedIdentifier>
            <ns2:studyFundingSponsor>
                <ns2:organization>
                    <name>Cancer Therapy Evaluation Program</name>
                    <nciInstituteCode>CTEP</nciInstituteCode>
                </ns2:organization>
                <studyInvestigators>
                    <ns2:studyInvestigator>
                        <roleCode>PI</roleCode>
                        <startDate>2009-05-06</startDate>
                        <ns2:siteInvestigator>
                            <ns2:investigator>
                                <firstName>Silvio</firstName>
                                <lastName>Berlusconi</lastName>
                            </ns2:investigator>
                        </ns2:siteInvestigator>
                    </ns2:studyInvestigator>
                </studyInvestigators>
                <studyPersonnels>
                    <ns2:studyPersonnel>
                        <roleCode>ae_rule_and_report_manager</roleCode>
                        <startDate>2012-03-21</startDate>
                        <ns2:researchStaff>
                            <firstName>Andrei</firstName>
                            <lastName>Abramovich</lastName>
                        </ns2:researchStaff>
                    </ns2:studyPersonnel>
                </studyPersonnels>
            </ns2:studyFundingSponsor>
        </fundingSponsor>
        <coordinatingCenter>
            <organizationAssignedIdentifier>
                <value>12345</value>
            </organizationAssignedIdentifier>
            <ns2:studyCoordinatingCenter>
                <ns2:organization>
                    <name>Cancer Therapy Evaluation Program</name>
                    <nciInstituteCode>CTEP</nciInstituteCode>
                </ns2:organization>
            </ns2:studyCoordinatingCenter>
        </coordinatingCenter>
        <studyOrganizations>
            <ns2:studySite>
                <ns2:organization>
                    <name>Mayo Clinic Rochester</name>
                    <nciInstituteCode>MN026</nciInstituteCode>
                </ns2:organization>
            </ns2:studySite>
        </studyOrganizations>
        <identifiers/>
        <treatmentAssignments>
            <ns2:treatmentAssignment>
                <code>TA1</code>
                <doseLevelOrder>1</doseLevelOrder>
                <description>(Cycle= 3 Weeks): Cisplatin 60 mg/m2 IV on day 1 Flavopiridol 100 mg/m2 CIV over 24 hours on day 1</description>
            </ns2:treatmentAssignment>
        </treatmentAssignments>
        <studyAgents>
            <ns2:studyAgent>
                <ns2:agent>
                    <name>Calcium carbonate</name>
                </ns2:agent>
                <indType>NA_COMMERCIAL</indType>
            </ns2:studyAgent>
        </studyAgents>
        <ctepStudyDiseases>
            <ns2:ctepStudyDisease>
                <ns2:diseaseTerm>
                    <term>Tinnitus1</term>
                </ns2:diseaseTerm>
                <leadDisease>false</leadDisease>
            </ns2:ctepStudyDisease>
        </ctepStudyDiseases>
        <evaluationPeriods>
            <ns2:evaluationPeriod>
                <name>Baseline</name>
                <epochOrder>0</epochOrder>
            </ns2:evaluationPeriod>
            <ns2:evaluationPeriod>
                <name>Treatment</name>
                <epochOrder>1</epochOrder>
                <solicitedAdverseEvents>
                    <ns2:solicitedAdverseEvent>
                        <ctepCode>10000081</ctepCode>
                    </ns2:solicitedAdverseEvent>
                    <ns2:solicitedAdverseEvent>
                        <ctepCode>10019211</ctepCode>
                    </ns2:solicitedAdverseEvent>
                    <ns2:solicitedAdverseEvent>
                        <ctepCode>10049737</ctepCode>
                    </ns2:solicitedAdverseEvent>
                </solicitedAdverseEvents>
            </ns2:evaluationPeriod>
            <ns2:evaluationPeriod>
                <name>Post-treatment</name>
                <epochOrder>2</epochOrder>
                <solicitedAdverseEvents>
                    <ns2:solicitedAdverseEvent>
                        <ctepCode>10000081</ctepCode>
                    </ns2:solicitedAdverseEvent>
                </solicitedAdverseEvents>
            </ns2:evaluationPeriod>
        </evaluationPeriods>
        <studyDevices />
        <expectedAECtcTerms>
            <ns2:expectedAECtcTerm>
                <ctepCode>10033371</ctepCode>
            </ns2:expectedAECtcTerm>
            <ns2:expectedAECtcTerm>
                <ctepCode>10012727</ctepCode>
            </ns2:expectedAECtcTerm>
            <ns2:expectedAECtcTerm>
                <ctepCode>10013781</ctepCode>
            </ns2:expectedAECtcTerm>
            <ns2:expectedAECtcTerm>
                <ctepCode>10016766</ctepCode>
            </ns2:expectedAECtcTerm>
            <ns2:expectedAECtcTerm>
                <ctepCode>10019211</ctepCode>
            </ns2:expectedAECtcTerm>
            <ns2:expectedAECtcTerm>
                <ctepCode>10028813</ctepCode>
            </ns2:expectedAECtcTerm>
        </expectedAECtcTerms>
    </ns2:study>
</ns2:studies>
